Sumitomo Pharma America, Inc. (United States)

Sumitomo Pharma America is the US subsidiary of Japanese pharmaceutical company Sumitomo Pharma. The company focuses on CNS disorders including schizophrenia, depression, and Parkinson’s disease through its Sunovion division. Key products include Latuda (lurasidone) for schizophrenia and bipolar depression. Sumitomo’s neuroscience research advances psychiatric and neurological treatments.